Kirov Military Medical Academy Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT01889433
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Federal State Military Higher Vocational Education Institution S.M. Kirov Military Medical Academy | S.M. Kirov Military Medical Academy

Active Ingredients

Drugs in Phase 3 Trials (1)

interferon alpha-2b (Intron-A) (1 trial)

Drugs in Phase 2 Trials (2)

cefepime (maxipeme) (1 trial)

fluticasone (cutivate) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

Infections (Phase 2)

Pseudomonas Infections (Phase 2)

Urinary Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3